To include your compound in the COVID-19 Resource Center, submit it here.

BenzaClin dermatology data

In an evaluator-blind trial in 132 patients, BenzaClin (Group 1) significantly

Read the full 119 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE